Objective: To explore the effect of mobile Internet on attitude and self-efficacy of patients with coronary heart disease (CHD) diagnosed by 12-lead Holter ECG.
Methods: The clinical data of 62 patients with CHD who underwent routine ECG examination (control group I) and 12-lead dynamic electrocardiogram (control group II) in our hospital (June 2017-December 2020) were retrospectively analyzed, and the clinical data of another 62 patients with CHD who received 12-lead Holter ECG examination combined with mobile Internet in our hospital at the same time (study group) were retrospectively analyzed. The clinical observation indexes of the three groups were compared.
Results: No obvious difference in general data among groups ( > 0.05). Compared with the control group I, the positive detection rate (PDR) of the study group and the control group II was obviously higher ( < 0.05), and the PDR of the study group was obviously higher than that of the control group II, without remarkable difference between both groups ( > 0.05). Compared with the control group, the scores of CAS-R of the study group were obviously higher ( < 0.05), and self-efficacy of daily life, health behaviors, medication compliance, and compliance behavior of the study group was obviously better ( < 0.05). The diagnostic efficacy was derived by ROC curve analysis, 12-lead Holter ECG combined with mobile Internet + routine ECG > 12-lead Holter ECG combined with mobile Internet > 12-lead Holter ECG > routine ECG.
Conclusion: Compared with the routine ECG, the sensitivity of 12-lead Holter ECG in the diagnosis of CHD is conspicuously higher. Meanwhile, 12-lead Holter ECG combined with mobile Internet can enhance the diagnostic efficiency and improve patients' perceived control attitude and self-efficacy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759848 | PMC |
| http://dx.doi.org/10.1155/2022/3414178 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Automatically optimized vectorcardiographic features are associated with recurrence of atrial fibrillation after electrical cardioversion.
Sci Rep
January 2025
Cardiocenter, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
Electrical cardioversion presents one of the treatment options for atrial fibrillation (AF). However, the early recurrence rate is high, reaching ~40% three months after the procedure. Features based on vectorcardiographic signals were explored to find association with early recurrence of AF.
View Article and Find Full Text PDFCatch-AF-Early Diagnosis of Symptomatic Arrythmias in the Waiting Period Prior to Seeing a Cardiologist in Victoria, British Columbia.
CJC Open
December 2024
Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.
Background: Atrial fibrillation (AF) is the most common cardiac arrhythmia. Given its often-paroxysmal nature, screening at a single time point, using a 12-lead electrocardiogram (ECG) or a Holter monitor, has limited benefit. The AliveCor KardiaMobile device is a validated ECG recorder that can be used for patient-directed arrhythmia diagnosis and symptom-rhythm correlation.
View Article and Find Full Text PDFDeceleration capacity derived from a five-minute electrocardiogram predicts mortality in the general population.
Sci Rep
December 2024
Department of Internal Medicine I, TUM University Hospital, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany.
In contemporary healthcare, effective risk stratification in the general population is vital amidst rising chronic disease rates and an ageing demographic. Deceleration Capacity of the heart rate (DC), derived from 24-hour Holter electrocardiograms, holds promise in risk stratification for cardiac patients. However, the potential of short-term electrocardiograms of five minutes duration for population screening has not been fully explored.
View Article and Find Full Text PDFConnected health: Ventricular tachycardia detection with Apple Watch-A case report.
Heliyon
December 2024
Centro Cardiologico Monzino IRCCS, 20138, Milan, Italy.
Background: Traditional screening methods, such as 12-lead electrocardiograms (ECGs) and Holter monitors, often fall short in detecting transient arrhythmias. However, advancements in wearable technology, like the Apple Watch®, enable real-time rhythm monitoring and specific arrhythmia detection through dedicated algorithms.
Case Description: A 60-year-old man with a history of arrhythmogenic cardiomyopathy and an implanted cardioverter-defibrillator (ICD), during a walk, experienced palpitations and dizziness; the Apple Watch® alerted him of an elevated heart rate.
Time-varying differences in stroke recurrence risk between types of atrial fibrillation based on screening methods and timing of detection.
Eur Stroke J
November 2024
Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Canada.
Article Synopsis
- * Results suggested that while ECG-AF had a lower risk of IS recurrence within the first year after the stroke, over the longer term, there was no significant difference compared to KAF.
- * Prolonged monitoring (AFDAS) consistently showed a lower risk for recurrent IS compared to KAF throughout the study, indicating potential advantages in identifying AF later on in terms of treatment outcomes.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!